Lijun Mu

1.2k total citations · 1 hit paper
31 papers, 901 citations indexed

About

Lijun Mu is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lijun Mu has authored 31 papers receiving a total of 901 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Immunology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lijun Mu's work include Immunotherapy and Immune Responses (8 papers), MicroRNA in disease regulation (5 papers) and RNA Interference and Gene Delivery (4 papers). Lijun Mu is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), MicroRNA in disease regulation (5 papers) and RNA Interference and Gene Delivery (4 papers). Lijun Mu collaborates with scholars based in China, Norway and United Kingdom. Lijun Mu's co-authors include Gustav Gaudernack, Gunnar Kvalheim, Yuefeng Du, Juanhua Tian, M. Häuser, Svein Dueland, Jon Amund Kyte, Qingzhi Long, Steinar Aamdal and T. A. Ryder and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Science Advances.

In The Last Decade

Lijun Mu

30 papers receiving 889 citations

Hit Papers

A nanoparticulate dual scavenger for targeted therapy of ... 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease
    2022 175 citations Chengxin Shi, Jianati Dawulieti et al. Science Advances profile →

Peers

Lijun Mu
Alessandro Gulino Italy
Hongsheng Zhou China
Rachel Hargest United Kingdom
Joyce Chan United States
Meng Lu China
Jingwei Yu China
Guanghua Rong China
Ramazan Rezaei Iran
Nadira Delhem France
Alessandro Gulino Italy
Lijun Mu
Citations per year, relative to Lijun Mu Lijun Mu (= 1×) peers Alessandro Gulino

Countries citing papers authored by Lijun Mu

Since Specialization
Citations

This map shows the geographic impact of Lijun Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijun Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijun Mu more than expected).

Fields of papers citing papers by Lijun Mu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijun Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijun Mu. The network helps show where Lijun Mu may publish in the future.

Co-authorship network of co-authors of Lijun Mu

This figure shows the co-authorship network connecting the top 25 collaborators of Lijun Mu. A scholar is included among the top collaborators of Lijun Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijun Mu. Lijun Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Jing, et al.. (2024). Gut microbiota contributes to the intestinal and extraintestinal immune homeostasis by balancing Th17/Treg cells. International Immunopharmacology. 143(Pt 3). 113570–113570. 17 indexed citations
3.
Li, Weiping, Jiaqing Liu, Yawei Tang, et al.. (2023). Mitochondrial ROS-dependent CD4+PD-1+T cells are pathological expansion in patients with primary immune thrombocytopenia. International Immunopharmacology. 122. 110597–110597. 5 indexed citations
4.
5.
Shi, Chengxin, Jianati Dawulieti, Feiyu Shi, et al.. (2022). A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease. Science Advances. 8(4). eabj2372–eabj2372. 175 indexed citations breakdown →
6.
Mu, Lijun, Yue Wang, Yuan Hu, et al.. (2022). The Role of TMIGD1 as a Tumor Suppressor in Colorectal Cancer. Genetic Testing and Molecular Biomarkers. 26(4). 174–183. 4 indexed citations
7.
Shi, Chengxin, Feiyu Shi, Qian Qin, et al.. (2021). Selenium-Containing Amino Acids Protect Dextran Sulfate Sodium-Induced Colitis via Ameliorating Oxidative Stress and Intestinal Inflammation. Journal of Inflammation Research. Volume 14. 85–95. 44 indexed citations
8.
Yuan, Bo, Chunlai Yin, Zhimin Lu, et al.. (2021). Differential effects of Huaier aqueous extract on human CD4+T lymphocytes from patients with primary immune thrombocytopenia. Experimental Hematology. 101-102. 58–67. 5 indexed citations
9.
Jiang, Yumei, et al.. (2020). <p>The Value of Prostate-Specific Antigen-Related Indexes and Imaging Screening in the Diagnosis of Prostate Cancer</p>. Cancer Management and Research. Volume 12. 6821–6826. 6 indexed citations
10.
Tian, Juanhua, Haibao Zhang, Lijun Mu, et al.. (2020). The miR-218/GAB2 axis regulates proliferation, invasion and EMT via the PI3K/AKT/GSK-3β pathway in prostate cancer. Experimental Cell Research. 394(1). 112128–112128. 21 indexed citations
11.
Mu, Lijun. (2020). MicroRNA-218 Inhibits Tumor Angiogenesis of Human Renal Cell Carcinoma by Targeting GAB2. Journal of the American College of Surgeons. 231(4). e257–e258. 4 indexed citations
12.
Guan, Bing, Lijun Mu, Linlin Zhang, et al.. (2018). MicroRNA‑218 inhibits the migration, epithelial‑mesenchymal transition and cancer stem cell properties of prostate cancer cells. Oncology Letters. 16(2). 1821–1826. 22 indexed citations
13.
Du, Yuefeng, Qingzhi Long, Bin Guan, et al.. (2018). Robot-Assisted Radical Prostatectomy Is More Beneficial for Prostate Cancer Patients: A System Review and Meta-Analysis. Medical Science Monitor. 24. 272–287. 82 indexed citations
14.
Dovedi, Simon J., Grazyna Lipowska‐Bhalla, Stephen A. Beers, et al.. (2016). Antitumor Efficacy of Radiation plus Immunotherapy Depends upon Dendritic Cell Activation of Effector CD8+ T Cells. Cancer Immunology Research. 4(7). 621–630. 44 indexed citations
15.
Guan, Bing, Kaijie Wu, Jin Zeng, et al.. (2016). Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer. Oncotarget. 8(5). 8162–8172. 55 indexed citations
16.
Honeychurch, Jamie, Monique Melis, Simon J. Dovedi, Lijun Mu, & Tim Illidge. (2013). Immunogenic potential of irradiated lymphoma cells is enhanced by adjuvant immunotherapy and modulation of local macrophage populations. Leukemia & lymphoma. 54(9). 2008–2015. 10 indexed citations
17.
18.
Kyte, Jon Amund, Lijun Mu, Steinar Aamdal, et al.. (2006). Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA. Cancer Gene Therapy. 13(10). 905–918. 162 indexed citations
19.
Mu, Lijun, Jon Amund Kyte, Gunnar Kvalheim, et al.. (2005). Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients. British Journal of Cancer. 93(7). 749–756. 85 indexed citations
20.
Mu, Lijun, et al.. (2003). A Protocol for Generation of Clinical Grade mRNA‐Transfected Monocyte‐Derived Dendritic Cells for Cancer Vaccines. Scandinavian Journal of Immunology. 58(5). 578–586. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandro Gulino Breakdown of academic impact, for papers by Hongsheng Zhou Breakdown of academic impact, for papers by Rachel Hargest Breakdown of academic impact, for papers by Joyce Chan Breakdown of academic impact, for papers by Meng Lu Breakdown of academic impact, for papers by Jingwei Yu Breakdown of academic impact, for papers by Guanghua Rong Breakdown of academic impact, for papers by Ramazan Rezaei Breakdown of academic impact, for papers by Nadira Delhem
Rankless by CCL
2026